Direct Oral Anticoagulants are High-Risk Medications with Potentially Complex Dosing | PSNet
Stroke Prevention in Atrial Fibrillation – The Use of NOACs in Everyday Clinical Practice | ECR Journal
rivaroxaban - General Practice notebook
Anesthesia&Analgesia on X: "Direct oral anticoagulant levels (apixaban and rivaroxaban) are important in certain situations: heparin anti-Xa activity could reliably detect apixaban, rivaroxaban, fondaparinux, and danaparoid #anticoagulant intensity ...
Full article: Laboratory testing of rivaroxaban in routine clinical practice: When, how, and which assays
Rivaroxaban Monitoring Example - - Evolving Practice: Role of Anti-Factor Xa Testing in Modern Anticoagulation
Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring | Thrombosis Journal | Full Text
Xarelto: Package Insert - Drugs.com
Evolving Practice: Role of Anti-Factor Xa Testing in Modern Anticoagulation
Spot Checks or Monitoring of NOACs for Anticoagulation Status | AER Journal
Performance of four different tests for rivaroxaban monitoring... | Download Table
Reversal of Novel Oral Anticoagulants
FDA Clears Rivaroxaban to Reduce the Risk of Major Cardiovascular Events | DAIC
New oral anticoagulants and regional anaesthesia - British Journal of Anaesthesia
Current status and populations of studies in the rivaroxaban... | Download Scientific Diagram
Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury | Semantic Scholar
Tentative algorithm for urgent monitoring of anticoagulation in... | Download Scientific Diagram
Evolving Practice: Role of Anti-Factor Xa Testing in Modern Anticoagulation
![Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13853/1/fig-5-2x.jpg "Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation [PeerJ]")
Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation [PeerJ]
Statistical correlation parameters between rivaroxaban con- | Download Table
Rivaroxaban: a fully-subsidised oral anticoagulant
A) Switching from VKAs to rivaroxaban. (B) Switching from rivaroxaban... | Download Scientific Diagram
